The company’s shares zoomed as much as 29 percent to 11,500 won ($9.45) in the
Rogers, one of the world’s best-known investment gurus, is the second largest shareholder of Korean
The stock has skyrocketed from 3,000 won in May after the company ventured into
Then it moved
In contrast to its aggressive move into a new venture, NanoMedics has scored poorly on its mainstay business. The company logged an operating loss of 11.4 billion won last year, jumping from 500 million won loss in 2017. Its debt ratio had hovered around 50 percent
- Source, Pulse News